Fluent

Fluent CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Fluent (TIUM.U.CN) as of Nov 5, 2026 is 11.01 %. In the previous year, Cash Return on Invested Capital (CROIC) was 10.11 % — a change of 8.81% (higher).

CROIC

11.01 %

YoY

8.81%

Last updated:

Cash Return on Invested Capital (CROIC) of Fluent is 2023 11.01 % . Cash Return on Invested Capital (CROIC) of Fluent was 2022 10.11 % . It decreases by 8.81% higher compared to the previous year.

The Fluent CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
-33.29 USD
Jan 1, 2020
2.83 USD
Jan 1, 2021
-18.80 USD
Jan 1, 2022
10.11 USD
Jan 1, 2023
11.01 USD
The Fluent CROIC history
YEARCROICYoY
11.01 %+8.81%
10.11 %-153.80%
-18.80 %-764.12%
2.83 %-108.50%
-33.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Cash Return on Invested Capital (CROIC) of Fluent is 11.01 % in 2023.

Cash Return on Invested Capital (CROIC) of Fluent changed from 10.11 % to 11.01 %, representing a 8.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Fluent since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Fluent with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Fluent

All Key Metrics — Fluent